Transasia showcases a holistic approach for clinical diagnostics at APPI 2017
Thursday, June 15, 2017
India’s leading in-vitro diagnostic company, Transasia Bio-Medicals Ltd. is proud to be the principal partner of the 4th Annual Conference of APPI- Mumbai scheduled from 16-18 June, 2017 at Renaissance Convention Centre Hotel, Mumbai. The annual conference hosted by the Association of Practicing Pathologists of India (APPI) is a conglomeration of industry experts from across the country.
With a vision of being committed to a Healthier and Happier World, Transasia Bio-Medicals Ltd. has been associated with APPI right since its inception. This year, Transasia has taken its participation to a whole new level in line with the introduction of new products and processes that provide an end-to-end solution for improved lab efficiency.
Sysmex XN-330, the latest six part differential hematology analyzer will be formally introduced at the event. This will be beneficial to laboratories as it offers the latest technology at an affordable cost. Transasia is the sole provider of Sysmex instruments in India and with XN-330, it endeavors to provide quality solutions that are cost effective.
In addition, Transasia will be showcasing its number 1 selling product- EM 200, a fully automated biochemistry analyzer. With over 2000 installations PAN India, EM 200 is the preferred choice for small, mid and chain laboratories and reaches out to over six crore patients. Transasia’s latest addition to the coagulation family, ECL 760 will also be showcased at the event.
Besides, Transasia is also organizing interactive scientific sessions and workshops led by experienced industry veterans in Hematology, Biochemistry and Coagulation. This will provide an important forum for practicing pathologists and lab owners to engage in a dialogue about critical compliance and operational challenges. This will also open the doors for further discussions on the best practice approaches for addressing those challenges.
On 17th June, Dr. Barnali Das, Consultant- Biochemistry & Immunology, Kokilaben Dhirubhai Ambani Hospital, Mumbai will be conducting a workshop on ‘Lean Six Sigma-How to cut the extra flab from your lab platter.’ The workshop exclusively hosted by Transasia, encompasses adoption of verification/validation protocol and Lean-Six Sigma to reduce errors and improve the lab efficiency. It will prove to be beneficial to laboratories as Lean Six-Sigma system can help labs achieve a number of objectives- reduce time traps, eliminate non-value-added steps, focus on the value added steps, and reduce complexity in the workflow process.
Dr. Das who holds a Green Belt in Six Sigma has already conducted this workshop as American Association of Clinical Chemistry (AACC) University’s short course in 2015 & 16. Infact the course was identified as the Best AACC course to be circulated in the Middle East and other countries.
Further during the day, Transasia will host a session on Middleware by Mr. S. Parthasarthy, CEO, CareData. This will focus on cloud base lab management system that efficiently scale up lab operations, improve TAT and help provide clinically accurate reports on time.
Day three of the conference will witness a motivational session on ‘A meaningful, fulfilled life’ by Dr. R. K. Anand, Emeritus Director, Dept. of Pediatrics, Jaslok Hospital, Mumbai. Dr. Anand is the senior-most pediatrician, author, researcher, teacher and crusader. As a former professor, he has worked tirelessly for the protection of children’s nutrition rights, for breast feeding healthcare practices and for research on infant feeding. Dr. Anand has worked with doyens in the field of pediatrics all over the world including Prof. R. S. Illingworth, U.K. and Dr. Waldo E. Nelson, U.S.A.He was the first pediatrician from India to ensure that the country has a strong code of marketing of milk formulas, feeding bottles, teats and pacifiers. His book Guide to Childcare, a national bestseller was considered by La Leche League International as the most breastfeeding –friendly book. Dr. Anand is a winner of the ‘Soul of Breastfeeding Award’ by World Alliance for Breastfeeding Action.
Further, Dr. (Col.) Dr. Jyoti Kotwal, Sr. Consultant- Hematology & Clinical Pathology at Sir Gangaram Hospital will be addressing the gathering on Futuristic Trends in Hematology. The focus of the workshop is to introduce new trends to the hematologists.
Over 1000 practicing pathologists form India and across the globe are participating during the three day event.
About Transasia Bio-Medicals Ltd.:
Incepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is recognized as India’s Largest In-vitro Diagnostic Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics.
Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba -Transasia Group has spread its footprint across USA, UK, Europe, Turkey and Eastern Europe, Russia and France, by means of various acquisitions – Erba Germany, Erba Czech Republic, Erba Russia, Erba Turkey, Erba France, Erba Diagnostics (USA), Erba Molecular (UK), Diamedix (USA), Delta Biologicals (Italy), ImmunoVision (USA), JAS Diagnostics Inc. (USA) and Drew Scientific (USA). Today, the Erba -Transasia Group serves millions across 104 countries.
The Erba -Transasia Group had added another feather to its cap by acquiring Lumora, a UK based patented molecular technology company. This makes the Group, one of the selected few global companies with its own patented technology for molecular testing. And recently the group strengthened its foray into immunoassay by acquiring Calbiotech Inc., USA. Calbiotech is the first company to introduce immunoassay kits in the United States to detect antibodies against Zika virus in human blood. It has more than 200 products, distributed to more than 60 countries. With this acquisition Transasia is all set to strengthen its foray into ELISA and CLIA assays for human and animal research, including specific assays for autoimmune disorders, cancer and infectious diseases. This is the 14th overseas IVD acquisition by Transasia in the last eight years.
Transasia manufactures and markets equipment and reagents, with an impressive install base of above 50,000 equipments across India. The vast network of more than 200 service engineers, 400+ Sales and Marketing Team, 21 zonal offices, and 350+ Distributors allows us to reach out to customers across the length and breadth of the country. Its foray into indigenous research has resulted in development of state of the art products and technologies, enabling Transasia’s deliverables to be synonymous with the best in the world.
Transasia has long endorsed the ‘Make in India’ concept, much before it actually came into existence! Infact it is the first Indian company to manufacture and export state-of-the-art blood analyzers and reagents, way back in the 1990s.
Transasia leaves no stone unturned in order to provide quality, accurate and affordable diagnostic solutions. ‘Transasia on the Move’ a first of its kind mobile van for the Indian IVD Industry, brings medical technology to the doorstep of healthcare professionals in towns and villages of India. Infact, in a short span of six months, Transasia on the Move has already reached out to over 2500 clinicians and lab professionals!
Every year over 200 million people benefit from tests done on Transasia’s equipment. Infact, one test every two seconds is conducted on a Transasia product!
Alliances with international partners like Sysmex Corporation (Japan), Medica (USA) and Diesse (Italy) have ensured that cutting edge technology and solutions is brought to India. Transasia markets, services and supports the Sysmex products and solutions in India.
All along its journey spanning more than three decades, Transasia has been recognized for its commitment to healthcare. The Economic Times, recently adjudged Transasia as the ‘Best Healthcare Brand-2016’. Besides this, Transasia has also been conferred ‘Global Growth Company-2014’ by the World Economic Forum amongst many others.
With a vision of being ‘Committed to a Healthier and Happier World’, Transasia continues to provide doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems.